Transplantation of placenta-derived mesenchymal stem cell-induced neural stem cells to treat spinal cord injury
查看参考文献24篇
文摘
|
Because of their strong proliferative capacity and multi-potency, placenta-derived mesenchymal stem cells have gained interest as a cell source in the ifeld of nerve damage repair. In the present study, human placenta-derived mesenchymal stem cells were induced to differentiate into neural stem cells, which were then transplanted into the spinal cord after local spinal cord injury in rats. The motor functional recovery and pathological changes in the injured spinal cord were observed for 3 successive weeks. The results showed that human placenta-derived mesenchymal stem cells can differentiate into neuron-like cells and that induced neural stem cells contribute to the resto-ration of injured spinal cord without causing transplant rejection. Thus, these cells promote the recovery of motor and sensory functions in a rat model of spinal cord injury. Therefore, human placenta-derived mesenchymal stem cells may be useful as seed cells during the repair of spinal cord injury. |
来源
|
Neural Regeneration Research
,2014,9(24):2197-2204 【核心库】
|
DOI
|
10.4103/1673-5374.147953
|
关键词
|
nerve regeneration
;
stem cells
;
placenta-derived mesenchymal stem cells
;
spinal cord injury
;
neural stem cells
;
nerve-like cells
;
motor function
;
sensory function
;
neural regeneration
|
地址
|
1.
Department of Orthopedics, Affiliated Central Hospital of Shenyang Medical College, Liaoning, Shenyang
2.
Department of Obstetrics, Affiliated Central Hospital of Shenyang Medical College, Liaoning, Shenyang
3.
Liaoning Province Wellcare Stem Cells Biotechnology Co., Ltd, Liaoning, Benxi
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
1673-5374 |
学科
|
基础医学;药学 |
基金
|
supported by a grant from the Scientific Research Program of Liaoning Provincial Science and Technology Ministry in China
|
文献收藏号
|
CSCD:5325092
|
参考文献 共
24
共2页
|
1.
Alimperti S. A novel lentivirus for quantitative assessment of gene knockdown in stem cell differentiation.
Gene Ther,2012,19:1123-1132
|
CSCD被引
1
次
|
|
|
|
2.
Alviano F. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro.
BMC Dev Biol,2007,7:11
|
CSCD被引
52
次
|
|
|
|
3.
Chen C H. Lentiviral vectors containing enhanced-green fluorescent protein gene labeling rabbit synovial mesenchymal stem cells.
Zhonghua Linchuang Yishi Zazhi: Dianzi Ban,2013,7:11476-11480
|
CSCD被引
1
次
|
|
|
|
4.
Grinev V V. Highly efficient transfer and stable expression of two genes upon lentivirus transduction of mesenchymal stem cells from human bone marrow.
Genetika,2012,48:389-400
|
CSCD被引
4
次
|
|
|
|
5.
Kadam S. Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes.
Rev Diabet Stud,2010,7:168-182
|
CSCD被引
11
次
|
|
|
|
6.
Li R P. The function of amnion in the differentiation of human umbilical cord blood cells into dopaminergic neurons.
Jiepou Xuebao,2008,39:790-794
|
CSCD被引
1
次
|
|
|
|
7.
Li Z. Human umbilical cord mesenchymal stem cell-loaded amniotic membrane for the repair of radial nerve injury.
Neural Regen Res,2013,8:3441-3448
|
CSCD被引
6
次
|
|
|
|
8.
Li Z. Chondrogenic differentiation of placenta-derived mesenchymal stem cells in vitro.
Zhongguo Zuzhi Gongcheng Yanjiu,2014,18:5203-5208
|
CSCD被引
1
次
|
|
|
|
9.
Lu G H. Isolation and multipotent differentiation of human decidua basalis- derived mesenchymal stem cells.
Nanfang Yike Daxue Xuebao,2011:31262-31265
|
CSCD被引
1
次
|
|
|
|
10.
Miao Z. Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells.
Cell Biol Int,2006,30:681-687
|
CSCD被引
40
次
|
|
|
|
11.
Nakamura T. Arthroscopic, histological and MRI analyses of cartilage repair after a minimally invasive method of transplantation of allogeneic synovial mesenchymal stromal cells into cartilage defects in pigs.
Cytotherapy,2012,14:327-328
|
CSCD被引
3
次
|
|
|
|
12.
Parolini O. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells.
Stem Cells,2008,26:300-311
|
CSCD被引
71
次
|
|
|
|
13.
Patel D M. Therapeutic potential of mesenchymal stem cells in regenerative medicine.
Stem Cells Int,2013,2013:496218
|
CSCD被引
10
次
|
|
|
|
14.
Portmann-Lanz C B. Turning placenta into brain: placental mesenchymal stem cells differentiate into neurons and oligodendrocytes.
Am J Obstet Gynecol,2010,202:294.e1-294.e11
|
CSCD被引
11
次
|
|
|
|
15.
Satija N K. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine.
J Cell Mol Med,2009,13:4385-4402
|
CSCD被引
18
次
|
|
|
|
16.
Shao M. Differentiation of in vitro cultured bone marrow mesenchymal stem cells into neurocytes and differential expression of protein.
Zhongguo Zuzhi Gongcheng Yanjiu Yu Linchuang Kangfu,2009,13:197-200
|
CSCD被引
1
次
|
|
|
|
17.
Shen J. Tissue engineering bone using autologous progenitor cells in the peritoneum.
PLoS One,2014,9:e93514
|
CSCD被引
2
次
|
|
|
|
18.
Shin M. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold.
Tissue Eng,2004,10:33-41
|
CSCD被引
33
次
|
|
|
|
19.
Sykova E. Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.
Cell Mol Neurobiol,2006,26:1113-1129
|
CSCD被引
21
次
|
|
|
|
20.
Ventura C. Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts.
J Biol Chem,2007,282:14243-14252
|
CSCD被引
22
次
|
|
|
|
|